SUMMARY: Yellow fever (YF), which is caused by a mosquito-borne virus, is an important viral hemorrhagic fever endemic in equatorial Africa and South America. Yellow fever virus (YFV) is the prototype of the family Flaviviridae and genus Flavivirus. The aim of this study was to determine the seroprevalence of YFV in selected health facilities in Western Kenya during the period 2010-2012. A total of 469 serum samples from febrile patients were tested for YFV antibodies using in-house IgM-capture ELISA, in-house indirect IgG ELISA, and 50z focus reduction neutralization test (FRNT 50 ). The present study did not identify any IgM ELISA-positive cases, indicating absence of recent YFV infection in the area. Twenty-eight samples (6z) tested positive for YFV IgG, because of either YFV vaccination or past exposure to various flaviviruses including YFV. Five cases were confirmed by FRNT 50 ; of these, 4 were either vaccination or natural infection during the YF outbreak in 1992-1993 or another period and 1 case was confirmed as a West Nile virus infection. Domestication and routine performance of arboviral differential diagnosis will help to address the phenomenon of pyrexia of unknown origin, contribute to arboviral research in developing countries, and enhance regular surveillance.
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Yellow fever (YF), a disease caused by mosquitoborne virus, is an important viral hemorrhagic fever endemic in equatorial Africa and South America (1,2). Yellow fever virus (YFV) is the prototype of the family Flaviviridae and genus Flavivirus (3). The genus Flavivirus contains approximately 70 viruses including YFV, dengue viruses (DENVs), Japanese encephalitis virus (JEV), and West Nile virus (WNV) that are of major human public health concern (4). An estimated annual incidence of 200,000 cases of YF causing 30,000 deaths is reported each affected individuals without treatment (4, 5) . In the eastern African region, YF outbreaks have been reported in Kenya (1992 Kenya ( -1993 (6, 7) , South Sudan (2003, 2005) (8, 9) , Uganda (2010-2011) (10), Sudan (2012) (11) , and Ethiopia (2013) (12) .
YF cases are difficult to diagnose from the clinical symptoms in the early stages of the illness because of`n on-specific influenza-like symptoms'' that are similar to those of other febrile illnesses. Differential diagnoses may include malaria, viral hepatitis, dengue, leptospirosis, or other hemorrhagic fevers (13) . WHO recommends case definition for suspected YF as``any case presenting with acute onset of fever, with jaundice appearing within 14 days after the onset of the first symptoms'' (14) . The aim of this study was to determine the seroprevalence of YFV in selected health facilities in 1829 ). In addition, positive control serum samples were kindly provided by Dr. R. Sang (KEMRI, Nairobi, Kenya) because Kenya has not had a recent YF outbreak other than the one from 1992-1993 (6,7). The negative controls used in the present study were generated from consenting healthy volunteers who had not received YFV vaccine or had no pre-exposure to YFV field infection. YFV (strain: 17D), DENV serotype 1 (DENV1) (strain: Hawaii), DENV serotype 2 (DENV2) (strain: 00St-22A), DENV serotype 3 (DENV3) (strain: SLMC50), DENV serotype 4 (DENV4) (strain: SLMC318), and WNV (strain: Eg101) were grown on either C6/36 (mosquito cell line) (15) or Vero cells (African green monkey kidney cell line).
Recent YFV exposure was checked using in-house IgM-capture ELISA following the protocol of Bundo and Igarashi (16) . A P/N (positive control [or sample] OD 492 /negative control OD 492 ) ratio of 2.0 was considered positive. In-house indirect IgG ELISA, which used sucrose-gradient purified YFV antigen, was performed for detection of YFV IgG (17) . Each sample was tested in duplicate and measured for mean OD 492 ; The IgG titer was calculated using a positive standard curve. With a cut-off value of positive IgG of 1:1,000 ＋ 3 standard deviations, a sample titer of 1:3,000 was considered IgG-positive for YFV (17, 18) . A 50z focus reduction neutralization test (FRNT 50 ) was used to determine the presence of YFV-specific neutralizing antibodies in test serum samples that were regarded as positive by IgM-capture ELISA and/or indirect IgG ELISA. The reciprocal of the endpoint serum dilution that provided a 50z reduction in the mean number of foci relative to the control wells that contained no serum was considered to be the FRNT 50 titer (19) . In-house flavivirus indirect IgG ELISA using a sucrose-gradient purified JEV antigen (strain ML17) was performed for the detection of flavivirus cross reactive IgG among the YFV indirect IgG ELISA positive samples (17) . The mean OD 492 for each serum sample was measured and IgG titers were calculated using a positive standard curve. With a cut-off value of positive IgG set at 1:1,000 ＋ 3 standard deviations, a sample titer of 1:3,000 was considered IgG positive for flavivirus (17, 18) . Data were analyzed using SPSS 20 (SPSS for Windows) (SPSS, Chicago, IL, US). IgG titers were expressed as the geometric mean. Analysis of variance (ANOVA) was used to compare means among the facilities. Correlation of the IgG titer with sex, age, and occupation was expressed as P values of Pearson's correlation coefficients. The level of significance was set at P ＜ 0.05.
In the present study, none of the samples tested positive for YFV IgM. Twenty-eight samples (6z) had YFV IgG titers of 3,000-12,000 (Table 1) (Fig. 1) . Among the 5 facilities, CIP showed the highest seropositivity; however, the GMT of positive YFV IgG titers was not statistically significant. There was a significant difference in YFV IgG seropositivity among the study sites (P ＝ 0.022). In addition, there was no significant difference in YFV IgG titer in terms of different age groups (P ＝ 0.857), sex (P ＝ 0.835), and occupation (P ＝ 0.496) (Tables 1 and 2 ). Twenty-eight samples that had YFV indirect IgG ELISA titers of 1:3,000 were further analyzed by FRNT 50 for confirmation of YFV infection using YFV, DENV1, DENV2, DENV3, DENV4, and WNV. Four out of the 28 YFV IgG-positive samples showed YFV-specific neutralization titers of 1:10. Notably, sample S0004 showed a neutralization titer of 1:640, whereas the other 3 samples, A0716, K0870, and K0960, showed neutralization titers of ＜1:100 (Table  2 ). In addition, none of the 4 samples showed a neutralization titer of 1:10 against DENV1, DENV2, DENV3, DENV4, and WNV. Moreover, K1013 showed a neutralization titer of 1:610 against WNV but 1:10 against YFV, DENV1, DENV2, DENV3, and DENV4. All 28 YFV IgG-positive samples yielded positive results for flavivirus indirect IgG ELISA using JEV (Fig. 2) .
In the present study, there was a 6z overall YFV IgG prevalence rate during the period 2010-2012 in selected parts of Western Kenya. In an earlier study by Mease et al. in 2011, an overall prevalence of 9.2z was recorded (20) . Notably, Busia showed prevalence rates of 3.2z, in Mease's study and 16.7z in the present study. However, the sampled population in Mease's study included mostly adults; in contrast, in the present study, both adults and children were included. Of the 3 sites in Trans Nzoia County is close to the Uganda border; of the 3 sites, END and AMC have a forest set-up upon account of nearness to Mt. Elgon while KDH has an urban set-up. However, the seroprevalence rates and GMT of IgG titers did not significantly differ among the 3 facilities. In the present study, KAP showed a relatively high prevalence rate of 7.7z even with the small sample set used; notably, KAP is located in close proximity to the region of the last major YFV outbreak in Kenya in 1992-1993 (21) .
Because there is cross-reactivity among flaviviruses, more so when flaviviruses are endemic in the same region, establishment of FRNT as a test will largely aid In the second index case, K1013, the sample was obtained from a 21-year-old non-YFV-vaccinated female from Sitatunga village, Kaplamai, Trans Nzoia County. Her YFV indirect IgG ELISA titer was 1:12,000; however, the YFV FRNT 50 titer was below 1:10 and WNV FRNT 50 titer was 1:610. This may be explained by past WNV exposure. These findings further underscore the need for differential diagnosis of arboviral infections in areas where more than 1 arbovirus is circulating. The remaining 23 samples could be due to other related flavivirus infections such as Zika virus, particularly from Busia. Furthermore, this study demonstrated that IgG can cross-react with YFV and other flaviviruses in indirect ELISA (Fig. 2) , suggesting that various flaviviruses may be circulating in this region.
This study showed that even if genetically distant from JEV complex, YFV serological cross-reactivity was strong. There is need for further refinement of ELISA assays, and the cut-off value of 1:3,000 could probably be redetermined.
